Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients—Correction

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.295.11.1252
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors

Unknown

Publisher

American Medical Association (AMA)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy